Sleep quality in schizophrenia and the effects of atypical antipsychotic medication

Acta Neuropsychiatrica

Volumn 16, Issue 6, 2004, Pages 281-289

  Haffmans, P M Judith ^a,c   Oolders, Hans J ^a   Hoencamp, Erik ^a   Schreiner, Andreas ^b  

^a Parnassia ^*  (Netherlands)

^b JANSSEN CILAG GMBH   (Germany)

^c PARNASSIA PSYCHIATRIC INSTITUTE   (Netherlands)

Author keywords

Atypical antipsychotics; Clozapine; Olanzapine; Risperidone; Schizophrenia; Sleep disorders

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

AROUSAL; DRUG EFFECT; HUMAN; MEDLINE; MENTAL DISEASE; REM SLEEP; REVIEW; SCHIZOPHRENIA; SELF EVALUATION; SLEEP; SLEEP STAGE; SLEEP TIME; SLOW WAVE SLEEP; SOCIAL PSYCHOLOGY;

EID: 22344456652     PISSN: 09242708     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0924-2708.2004.00103.x     Document Type: Review

References (48)

1. DURSUN SM, PATEL JKM, BURKE JG et al. Effects of typical antipsychotic drugs and risperidone on the quality of sleep in patients with schizophrenia: a pilot study. J Psychiatry Neurosci 1999;24:333-337.
2. HAFFMANS PMJ, HOENCAMP E, KNEGTERING HJ et al. Sleep disturbance in schizophrenia. Br J Psychiatry 1994;65:697-698.
3. VAN KäMMEN DP, VAN KäMMEN WB, PETERS JL et al. CSF MHPG, sleep and psychosis in schizophrenia. Clin Neuropharmacol 1986;9:575-577.
4. KESHAVAN MS, REYNOLDS CF, KUPFER DJ. Electroencephalographic sleep in schizophrenia: a critical review. Compr Psychiatry 1990;30:34-47.
5. DEMENT W. Dream recall and eye movements during sleep in schizophrenics and normals. J Nerv Ment Dis 1955;122:263-269.
6. RECHTSCHAFFEN A, SCHULSINGER F, MEDNICK S. Schizophrenia and physiological indices of dreaming. Arch Gen Psychiatry 1964;10:89-93.
7. TANDON R, SHIPLEY JE, EISER AS et al. Association between abnormal REM sleep and negative symptoms in schizophrenia. Psychiatry Res 1989;27:359-361.
8. TAYLOR SF, TANDON R, SHIPLEY JE et al. Sleep onset REM periods in schizophrenic patients. Biol Psychiatry 1991;30:205-209.
9. KESHAVAN MS, REYNOLDS CF III, MIEWALD J et al. Slow-wave sleep deficits and outcome in schizophrenia and schizoaffective disorder. Acta Psychiatr Scand 1995;91:289-292.
10. KATO M, KAJIMURA N, OKUMA T et al. Association between delta waves during sleep and negative symptoms in schizophrenia. Neuropsychobiology 1999;39:165-172.
11. KAPLAN J, DAWSON S, VAUGHAN T et al. Effect of prolonged chlorpromazine administration on the sleep of chronic schizophrenics. Arch Gen Psychiatry 1974;31:62-66.
12. GILLIN JC, VAN KäMMEN DP, POST R et al. Effects of prolonged administration of pimozide on sleep-EEG patterns in psychiatric patients. Commun Psychopharmacol 1977;1:225-232.
13. KESHAVAN M, REYNOLDS C, BRAR J et al. Sleep EEG changes in schizophrenia during haloperidol treatment. Biol Psychiatry 1989;25:181A.
14. TAYLOR SF, TANDON R, SHIPLEY JE et al. Effect of neuroleptic treatment on polysomnographic measures in schizophrenia. Biol Psychiatry 1991;30:904-912.
15. TANDON R, ELSER A, TAYLOR S et al. Effects of clozapine, risperidone and olanzapine on polysomnographic measures in schizophrenia. Schizophr Res 2000;41:156.
16. BLUM A, GIRKE W. Marked increase in REM sleep produced by a new antipsychotic compound. Clin Electroencephalogr 1973;4:80-84.
17. RUTHER E, DAVIS L, PAPOUSEK M et al. Pharmakologische Beeinflussung zentraler serotonerger Mechanismen am Menschen und Auswirkung auf den Schlaf. Drug Res 1976;26:1071-1073.
18. HINZE-SELCH D, MULLINGTON J, ORTH A et al. Effects of clozapine on sleep: a longitudinal study. Biol Psychiatry 1997;42:260-266.
19. LEE JH, Woo JI, MELTZER HY. Effects of clozapine on sleep measures and sleep-associated changes in growth hormone and cortisol in patients with schizophrenia. Psychiatr Res 2001;103:157-166.
20. WETTER TC, LAUER CJ, GILLICH G et al. The electroencephalographic sleep pattern in schizophrenic patients treated with clozapine or classical antipsychotic drugs. J Psychiatr Res 1996;30:411-419.
21. 2c receptors in vivo. Biol Psychiatry 2000;47:468-470.
22. 2c receptor (HT2RC) and the increase in slow wave sleep produced by olanzapine. Psychpharmacology 2001;153:271-272.
23. LINDBERG N, VIRKKUNEN M, TANI P et al. Effect of a single-dose of olanzapine on sleep in healthy females and males. Int CHn Psychopharmacol 2002;17:177-184.
24. SALIN-PASCUAL RJ, HERRERA-ESTRELLA M, GALICIAPOLO L et al. Olanzapine acute administration in schizophrenic patients increases delta sleep and sleep efficiency. Biol Psychiatry 1999;46:141-143.
25. DE BUCK R, HOFFMAN G, DE SMET S et al. Risperidone in young chronic schizophrenic patients: a polysomnographic study. Biol Psychiatry 1991;29 (11S):419S.
26. WILLIAMS R. Optimal dosing with risperidone: update recommendations. J Clin Psychiatry 2001; 62:282-289.
27. ROYUELA-RIOO A, MACIAS JA, AGUADO JA. Effect of chronic use of risperidone on sleep quality. Int J Neuropsychopharmacol 1999;2:102-103.
28. ROYUELA A, MACIAS JA. Effects of risperidone and other antipsychotic agents on sleep quality. Eur Neuropsychopharmacol 1997;7:S210.
29. CROSTHWAITE CG, REVELEY MA. Improved sleep with risperidone compared with conventional antipsychotic drugs in older patients with psychosis. Schizophr Res 2000;41:202.
30. SPITZER RL, GIBBON M, ENDICOTT J. The global assessment scale: a procedure for measuring overall severity of psychiatric disturbances. Arch General Psychiatry 1976;33:766-771.
31. HAFFMANS PMJ, OOLDERS H, HOENCAMP E et al. The effect of risperidone versus haloperidol on sleep patterns of schizophrenic patients: results of a double blind randomised pilot trial. Eur Neuropsychopharmacol 2001;11:S260.
32. YAMASHITA H, MORINOBU S, YAMAWAKI S, HORIGUCHI J, NAGAO M. Effect of risperidone on sleep in schizophrenia: a comparison with haloperidol. Psychiatry Res 2002;109:137-142.
33. SEEMAN P, CHAU-WONG M, WONG K. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 1976;261:717-719.
34. GOTTESMANN C. The neurochemistry of waking and sleeping mental activity: the disinhibition-dopamine hypothesis. Psychiatry Clin Neurosci 2002;56:345-354.
35. LEYSEN JE, JANSSEN PMF, HEYLEN L et al. Receptor interactions of new antipsychotics: Relation to pharmacodynamic and clinical effects. Int J Psychiatry Clin Pract 1998;2:S3-S17.
36. JOUVET M. Biogenic amines and the states of sleep. Science 1969;163:32-41.
37. KOELLA WP. Serotonin and sleep. In: KOELLA WP, RUTHER E, SCHUIZ H, eds. Sleep, 1984. Proceedings of the Seventh European Congress on Sleep Research. Stuttgart: Gustav Fischer Verlag, 1985:6-10.
38. 2 receptors. Neuropharmacology 1994;33:467-471.
39. SHARPLEY AL, COWEN PJ. Effect of pharmacologic treatment on the sleep of depressed patients. Biol Psychiatry 1995;37:85-98.
40. 2 antagonistic properties. J Pharmacol Exp Ther 1988; 244:685-693.
41. LEYSEN J, JANSSEN P, GOMMEREN W et al. In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel neuroleptics risperidone and ocaperidone. Mol Pharmacol 1992;41:494-508.
42. RUES VI. Olanzapine: a novel atypical neuroleptic agent. Lancet 1997;349:1264-1265.
43. MASON SL, REYNOLDS GP. Clozapine has sub-micromolar affinity for 5-HT1A receptors in human brain tissue. Eur J Pharmacol 1992;221:397-398.
44. DRIVER HS, FLANIGAN MJ, BENTLEY AJ et al. The influence of ipsaspirone, a 5-HT1A agonist, on sleep patterns of healthy subjects. Psychopharmacology 1995;117:186-192.
45. SCHWALEN S. Risperidone (Risperdal®) effects on sleep-wake cycle disturbances in dementia. Int Psychogeriatr 2001;13 (Suppl. 2):P-261.
46. NOFZINGER EA, VAN KAMMEN DP, GILBERTSON MW et al. Electroencephalographic sleep in clinically stable schizophrenic patients: two-week versus six-week neuroleptic-free. Biol Psychiatry 1993;33:829-835.
47. NEYLAN TC, VAN KAMMEN DP, KELLEY ME et al. Sleep in schizophrenic patients on and off haloperidol therapy: clinically stable versus relapsed patients. Arch Gen Psychiatry 1992;49:643-649.
48. CAMPBELL A, BALDESSARINI RJ. Prolonged pharmacologic activity of neuroleptics. Arch Gen Psychiatry 1985;42:637.